Ulcerative Colitis or Crohn's Disease research hub

A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease Long-term Safety With Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease.

This study looks at the long-term safety of a medicine called Entyvio for children and young people with Crohn's disease or ulcerative colitis. It aims to see how safe the treatment is over time and if it causes any side effects.